More on SOMMY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $17.00 |
|
|||
| Open | $17.00 | ||||
| 52 Wk High | $30.01 | ||||
| 52 Wk Low | $19.54 | ||||
| Day High | $17.00 | ||||
| Day Low | $17.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 52 | ||||
- Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW590 at Nomura/Instinet
- Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Lowered to KRW460 at Axis Capital Limited
- Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW460 at Nomura/Instinet
- Valent BioSciences partners with Seipasa for U.S. biostimulant market
- Valent BioSciences and Seipasa Form Strategic Partnership to Bring Novel Biostimulant Products to the U.S. Market
- Valent BioSciences, MGK, and Valent North America Become Sumitomo Biorational Company, a Global Center of Excellence for Biorational Innovation
- Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW415 at Nomura/Instinet
- Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW520 at JPMorgan
- Morgan Stanley Reiterates Overweight Rating on Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY)
- Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Lowered to KRW320 at Nomura/Instinet
Entities mentioned with SOMMY
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- Robert W Baird | View Related Stories »
- S3 | View Related Stories »
- IPO | View Related Stories »
- Show More...
